-
1
-
-
0035810147
-
Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia
-
DOI 10.1056/NEJM200104053441401
-
Druker BJ, Talpaz M, Resta DJ, Peng B, Buchdunger E, Ford JM, et al. Efficacy and safety of a specific inhibitor of the BCRABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 2001;344:1031-7. (Pubitemid 32267972)
-
(2001)
New England Journal of Medicine
, vol.344
, Issue.14
, pp. 1031-1037
-
-
Druker, B.J.1
Talpaz, M.2
Resta, D.J.3
Peng, B.4
Buchdunger, E.5
Ford, J.M.6
Lydon, N.B.7
Kantarjian, H.8
Capdeville, R.9
Ohno-Jones, S.10
Sawyers, C.L.11
-
2
-
-
21344462378
-
Cutaneous side-effects of kinase inhibitors and blocking antibodies
-
DOI 10.1016/S1470-2045(05)70243-6, PII S1470204505702436
-
Robert C, Soria JC, Spatz A, Le Cesne A, Malka D, Pautier P, et al. Cutaneous side-effects of kinase inhibitors and blocking antibodies. Lancet Oncol 2005;6:491-500. (Pubitemid 40903630)
-
(2005)
Lancet Oncology
, vol.6
, Issue.7
, pp. 491-500
-
-
Robert, C.1
Soria, J.-C.2
Spatz, A.3
Le, C.A.4
Malka, D.5
Pautier, P.6
Wechsler, J.7
Lhomme, C.8
Escudier, B.9
Boige, V.10
Armand, J.-P.11
Le, C.T.12
-
3
-
-
64749099585
-
Effets cutanés des nouvelles molécules utilisées en cancérologie
-
Mateus C, Robert C. Effets cutanés des nouvelles molécules utilisées en cancérologie. Rev Med Interne 2009;30: 401-10.
-
(2009)
Rev Med Interne
, vol.30
, pp. 401-410
-
-
Mateus, C.1
Robert, C.2
-
4
-
-
0036816328
-
Imatinib-induced acute generalized exanthematous pustulosis (AGEP) in two patients with chronic myeloid leukemia
-
DOI 10.1034/j.1600-0609.2002.02830.x
-
Schwarz M, Kreuzer KA, Baskaynak G, Dörken B, le Coutre P. Imatinib-induced acute generalized exanthematous pustulosis (AGEP) in two patients with chronic myeloid leukemia. Eur J Haematol 2002;69:254-6. (Pubitemid 35448131)
-
(2002)
European Journal of Haematology
, vol.69
, Issue.4
, pp. 254-256
-
-
Schwarz, M.1
Kreuzer, K.-A.2
Baskaynak, G.3
Dorken, B.4
Le, C.P.5
-
5
-
-
33744537616
-
Imatinib mesylate and dermatology part 2: A review of the cutaneous side effects of imatinib mesylate
-
Scheinfeld N. Imatinib mesylate and dermatology part 2: a review of the cutaneous side effects of imatinib mesylate. J Drugs Dermatol 2006;5:228-31.
-
(2006)
J Drugs Dermatol
, vol.5
, pp. 228-231
-
-
Scheinfeld, N.1
-
6
-
-
0035939714
-
Cutaneous reactions to STI571
-
Brouard M, Saurat JH. Cutaneous reactions to STI571. N Engl J Med 2001;345:618-9.
-
(2001)
N Engl J Med
, vol.345
, pp. 618-619
-
-
Brouard, M.1
Saurat, J.H.2
-
7
-
-
0344556916
-
Adverse cutaneous reactions to imatinib (STI571) in Philadelphia chromosome-positive leukemias: A prospective study of 54 patients
-
DOI 10.1067/mjd.2003.44
-
Valeyrie L, Bastuji-Garin S, Revuz J, Bachot N, Wechsler J, Berthaud P, et al. Adverse cutaneous reactions to imatinib (STI571) in Philadelphia chromosome-positive leukemias: a prospective study of 54 patients. J Am Acad Dermatol 2003;48:201-6. (Pubitemid 36232317)
-
(2003)
Journal of the American Academy of Dermatology
, vol.48
, Issue.2 SUPPL.
, pp. 201-206
-
-
Valeyrie, L.1
Bastuji-Garin, S.2
Revuz, J.3
Bachot, N.4
Wechsler, J.5
Berthaud, P.6
Tulliez, M.7
Giraudier, S.8
-
8
-
-
0142120490
-
Panniculitis in a patient with chronic myelogenous leukaemia treated with imatinib [15]
-
DOI 10.1046/j.1365-2133.2003.05594.x
-
Ugurel S, Lahaye T, Hildenbrand R, Glorer E, Reiter A, Hochhaus A, et al. Panniculitis in a patient with chronic myelogenous leukaemia treated with imatinib. Br J Dermatol 2003;149:678-9. (Pubitemid 37281620)
-
(2003)
British Journal of Dermatology
, vol.149
, Issue.3
, pp. 678-679
-
-
Ugurel, S.1
Lahaye, T.2
Hildenbrand, R.3
Glorer, E.4
Reiter, A.5
Hochhaus, A.6
Schadendorf, D.7
Goerdt, S.8
-
9
-
-
33745102555
-
Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias
-
DOI 10.1056/NEJMoa055229
-
Talpaz M, Shah NP, Kantarjian H, Donato N, Nicoll J, Paquette R, et al. Dasatinib in imatinib-resistant Philadelphia chromosomepositive leukemias. N Engl J Med 2006;354:2531-41. (Pubitemid 43882349)
-
(2006)
New England Journal of Medicine
, vol.354
, Issue.24
, pp. 2531-2541
-
-
Talpaz, M.1
Shah, N.P.2
Kantarjian, H.3
Donato, N.4
Nicoll, J.5
Paquette, R.6
Cortes, J.7
O'Brien, S.8
Nicaise, C.9
Bleickardt, E.10
Blackwood-Chirchir, M.A.11
Iyer, V.12
Chen, T.-T.13
Huang, F.14
Decillis, A.P.15
Sawyers, C.L.16
-
10
-
-
77953668914
-
Severe toxicity of skin rash, fever and diarrhea associated with imatinib: Case report and review of skin toxicities associated with tyrosine kinase inhibitors
-
Huang X, Patel S, Ahmed N, Seiter K, Liu D. Severe toxicity of skin rash, fever and diarrhea associated with imatinib: case report and review of skin toxicities associated with tyrosine kinase inhibitors. Drug Des Devel Ther 2009;2:215-9.
-
(2009)
Drug Des Devel Ther
, vol.2
, pp. 215-219
-
-
Huang, X.1
Patel, S.2
Ahmed, N.3
Seiter, K.4
Liu, D.5
-
11
-
-
33745059989
-
Panniculitis during dasatinib therapy for imatinib-resistant chronic myelogenous leukemia [17]
-
DOI 10.1056/NEJMc053425
-
Assouline S, Laneuville P, Gambacorti-Passerini C. Panniculitis during dasatinib therapy for imatinib-resistant chronic myelogenous leukemia. N Engl J Med 2006;354:2623-4. (Pubitemid 43882376)
-
(2006)
New England Journal of Medicine
, vol.354
, Issue.24
, pp. 2623-2624
-
-
Assouline, S.1
Laneuville, P.2
Gambacorti-Passerini, C.3
-
12
-
-
1342321790
-
Sweet's syndrome with CML cell infiltration of the skin in a patient with chronic-phase CML while taking Imatinib Mesylate
-
Liu D, Seiter K, Mathews T, Madahar CJ, Ahmed T. Sweet's syndrome with CML cell infiltration of the skin in a patient with chronic-phase CML while taking Imatinib Mesylate. Leuk Res 2004;1:S61-3.
-
(2004)
Leuk Res
, vol.1
-
-
Liu, D.1
Seiter, K.2
Mathews, T.3
Madahar, C.J.4
Ahmed, T.5
-
13
-
-
14944383796
-
Imatinib-induced sweet syndrome in a patient with chronic myeloid leukemia
-
DOI 10.1001/archderm.141.3.368
-
Ayirookuzhi SJ, Ma L, Ramshesh P, Mills G. Imatinib-induced Sweet syndrome in a patient with chronic myeloid leukemia. Arch Dermatol 2005;141:368-70. (Pubitemid 40365453)
-
(2005)
Archives of Dermatology
, vol.141
, Issue.3
, pp. 368-370
-
-
Ayirookuzhi, S.J.1
Ma, L.2
Ramshesh, P.3
Mills, G.4
-
14
-
-
0033005377
-
Sweet's syndrome associated with chronic myelogenous leukemia: Demonstration of leukemic cells within a skin lesion
-
DOI 10.1016/S0190-9622(99)70206-9
-
Urano Y, Miyaoka Y, Kosaka M, Kabe K, Uchida N, Arase S. Sweet's syndrome associated with chronic myelogenous leukemia: demonstration of leukemic cells within a skin lesion. J Am Acad Dermatol 1999;40:275-9. (Pubitemid 29072813)
-
(1999)
Journal of the American Academy of Dermatology
, vol.40
, Issue.2 I
, pp. 275-279
-
-
Urano, Y.1
Miyaoka, Y.2
Kosaka, M.3
Kabe, K.4
Uchida, N.5
Arase, S.6
-
15
-
-
0842310881
-
Neutrophilic panniculitis
-
DOI 10.1016/j.jaad.2003.10.006
-
Sutra-Loubet C, Carlotti A, Guillemette J, Wallach D. Neutrophilic panniculitis. J Am Acad Dermatol 2004;50:280-5. (Pubitemid 38174292)
-
(2004)
Journal of the American Academy of Dermatology
, vol.50
, Issue.2
, pp. 280-285
-
-
Sutra-Loubet, C.1
Carlotti, A.2
Guillemette, J.3
Wallach, D.4
-
16
-
-
51349092418
-
Subcutaneous sweet syndrome
-
Guhl G, García-Díez A. Subcutaneous sweet syndrome. Dermatol Clin 2008;26:541-51.
-
(2008)
Dermatol Clin
, vol.26
, pp. 541-551
-
-
Guhl, G.1
García-Díez, A.2
|